Wednesday’s big stock stories: What’s likely to move the market in the next trading session

Major banks are boosting dividends and authorizing buybacks after stress tests confirmed ample capital, driving their shares higher. Conversely, Centene shares plunged nearly 25% after hours, withdrawing its 2025 earnings forecast following significant Medicaid cuts. Elsewhere, technical analysts predict short-term upside for Apple despite its year-to-date underperformance, while Tesla and Rivian await Q2 delivery figures amidst recent stock weakness, and Verint gained over 12% on buyout speculation.

Analysis

The financial sector is exhibiting significant strength, with major banks including Goldman Sachs, Morgan Stanley, JPMorgan, and Bank of America uniformly increasing dividends following successful Federal Reserve stress tests. This coordinated capital return, which includes stock buybacks, has propelled their stocks to recent highs, with gains ranging from 7% to 15% in the past month, signaling robust balance sheets and management confidence. In sharp contrast, the healthcare insurance sector faces a severe headwind, exemplified by Centene (CNC), which saw its shares plunge approximately 25% in after-hours trading. The company withdrew its 2025 earnings forecast, a direct response to the Senate approving the deepest cuts to Medicaid since 1965, indicating a material negative impact on its future revenue streams. Elsewhere, Apple (AAPL) is receiving bullish short-term technical forecasts, with analysts predicting a potential 6% to 16% 'counter-trend relief rally' despite the stock being down 17% year-to-date. The EV sector, particularly Tesla (TSLA) and Rivian (RIVN), is under pressure ahead of their Q2 delivery announcements, with Tesla's stock falling for six consecutive days amid political friction that could jeopardize its autonomous driving plans. Finally, a potential M&A catalyst has emerged for Verint (VRNT), which surged over 12% on reports of buyout interest from Thoma Bravo.

Key Decisions for Investors

• Given the wave of dividend hikes and buybacks, investors may find the banking sector attractive for its enhanced shareholder returns and demonstration of financial stability.
• The withdrawal of Centene's 2025 guidance due to legislative Medicaid cuts represents a significant fundamental risk, warranting a cautious stance and a re-evaluation of exposure to health insurers heavily reliant on government programs.
• While technical analysts see a short-term relief rally for Apple, investors should recognize this as a potential 'counter-trend' move and weigh it against the stock's significant year-to-date underperformance.
• Investors in Tesla and Rivian should brace for volatility around the upcoming Q2 delivery reports, as these figures will be a critical catalyst for stocks already facing negative momentum and, in Tesla's case, political headwinds.
• The reported buyout interest in Verint offers a speculative, event-driven catalyst, but positions should be managed with awareness that the gains could reverse if a formal deal does not materialize.